You are here

Company Monitoring Page for Genentech

latest headlines for company on cafepharma

FDA says asthma drug Xolair raises risk of heart, brain problems

Reuters

Mon, 09/29/14 - 02:00 pm

Tags:

FDA, Xolair, asthma, Roche, Genentech

Roche's Genentech triggers its PhIII program for blockbuster AMD contender

Fierce Biotech

Mon, 09/15/14 - 10:51 am

Tags:

Roche, Genentech, AMD, Chroma, Spectri

FDA approves Avastin for aggressive and late-stage cervical cancer

Pharmaforum

Fri, 08/15/14 - 05:37 am

Tags:

FDA, cervical cancer, Avastin, Genentech, Roche

Genentech Submits sBLA for Diabetic Retinopathy Drug

Drug Discovery and Development

Fri, 08/8/14 - 05:08 pm

Tags:

Genentech, Roche, diabetic retinopathy, Lucentis

Genentech granted FDA orphan status for gastric cancer treatment

Yahoo/Fly on the Wall

Fri, 05/2/14 - 09:53 am

Tags:

Genentech, FDA, gastric cancer, cancer of the gastro-esophageal junction, orphan drugs, Ipatasertib

Genentech wins FDA approval for Xolair to treat hives

San Francisco Chronicle, CA

Sat, 03/22/14 - 12:19 pm

Tags:

Genentech, Xolair, hives

PDL Biopharma: Agreement With Genentech And Roche Is A Net Negative

Seeking Alpha

Tue, 02/4/14 - 09:58 am

Tags:

PDL Biopharma, Roche, Genentech, Avastin, Herceptin, Lucentis Xolair, Kadcyla, Perjeta, Lucentis

Opportunities in Lung Cancer Therapies

Motley Fool

Sun, 11/24/13 - 12:30 pm

Tags:

lung cancer, non-small cell lung cancer, Avastin, Genentech, Roche, Tarceva, AstraZeneca, Iressa, Alimta, selumetinib, Array Biopharma, CO-1686, Clovis Oncology, AP26113, Ariad Pharmaceuticals

FDA puts a clamp on Curis cancer drug program after patient dies of liver failure

Fierce Biotech

Wed, 11/6/13 - 10:37 am

Tags:

liver failure, Genentech, FDA, Curis, CUDC-427, breast cancer

David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech

Xconomy

Thu, 10/17/13 - 08:36 am

Tags:

David Schenkein, Agios Pharmaceuticals, Genentech

Novartis' omalizumab shines in third PhIII hives trial

Pharma Times, UK

Mon, 10/7/13 - 08:52 am

Tags:

Novartis, chronic spontaneous urticaria, omalizumab, Xolair, Genentech

Top 15 Drug Launch Superstars

Fierce Pharma

Thu, 10/3/13 - 10:35 am

3 Key Points From Sarepta's Eteplirsen Study Update (And They're Positive)

TheStreet.com

Thu, 09/26/13 - 10:35 am

Tags:

Sarepta, eteplirsen, Genentech, GSK, Duchenne Muscular Dystrophy

Is Seattle Genetics an Acquisition Target?

Motley Fool

Tue, 09/10/13 - 10:26 am

Tags:

M&A, Seattle Genetics, Adcetris, Bayer, AbbVie, Genentech

Roche's (RHHBY) Genentech Receives FDA Priority Review for Perjeta

Street Insider

Tue, 07/2/13 - 09:38 am

Tags:

Roche, Genentech, FDA, Perjeta, breast cancer

Drug lawsuit against Genentech could burden customers

San Francisco Examiner, CA

Mon, 06/24/13 - 10:46 am

Tags:

Genentech, PDL Biopharma

PDL BioPharma wants arbitration in royalty dispute

Yahoo/AP

Tue, 06/11/13 - 12:11 pm

Tags:

Roche, Genentech, PDL Biopharma

Why Did Immunotherapy Pioneer NewLink Genetics Reach A 52-Week High?

Seeking Alpha

Mon, 06/10/13 - 12:23 pm

Tags:

immunotherapy, NewLink Genetics, Roche, Genentech, Bristol-Myers Squibb, Merck, HyperAcute Lung, HyperAcute Pancreas

Bristol-Myers Sues Genentech Over ‘Cabilly’ Patents

Bloomberg

Wed, 05/8/13 - 09:08 am

Tags:

Genentech, Bristol-Myers Squibb, patents, Cabilly, melanoma, colon cancer

Another Biosimilar Legislative Defeat For Amgen & Genentech

Pharmalot

Tue, 05/7/13 - 11:43 am

Tags:

biosimilars, Amgen, Genentech

Pages

last 30 twitter posts